Antineoplastic Combined Chemotherapy ProtocolsBCG VaccineCystectomy
Dr. Richard S. Hudes, MD
NPI1891796926PAC ID2264438050
- Medicare services, 2024
- 6,500
- Medicare patients, 2024
- 452
- Part D claims, 2024
- 88
- Publications
- 8
- Clinical trials
- 9
- Practice address
- 2 Park Center Ct, Owings Mills, MD 21117
- Practice phone
- Call (410) 581-1600
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Chesapeake Urology Associates
Owings Mills, Maryland
Find Dr. Hudes' professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Richard S. Hudes is a radiation oncologist in Owings Mills, Maryland
Dr. Hudes practices at Chesapeake Urology Associates in Owings Mills, Maryland.
Dr. Hudes' NPI, 1891796926, was assigned on August 10, 2005. Dr. Hudes graduated from Medical College of Georgia School of Medicine in 1995. Dr. Hudes holds Maryland license D0055908.
NPI and contact details
- NPI
- 1891796926NPI Registry (opens in a new tab)
- Medicare PAC ID
- 2264438050
- NPI enumeration date
- August 10, 2005
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (410) 581-1600
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 57
- Medical school graduation
- 1995
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Richard S. Hudes practices at Chesapeake Urology Associates in Owings Mills, Maryland
Dr. Hudes' primary practice is Chesapeake Urology Associates, at 2 Park Center Ct, Owings Mills, MD 21117 in Baltimore County. The practice phone is (410) 581-1600.
- Chesapeake Urology Associates2 Park Center Ct, Owings Mills, MD 21117 · Baltimore CountyPhone(410) 581-1600
Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data
Dr. Richard S. Hudes is affiliated with 2 sites of care and 3 medical groups
Dr. Hudes' primary practice is Chesapeake Urology Associates in Owings Mills, Maryland. Dr. Hudes is also affiliated with Ascension Saint Agnes Hospital. The medical group on file is Chesapeake Urology Associates. Dmand AI also links Dr. Hudes to 2 more medical groups, each named with a free account.
Chesapeake Urology AssociatesPrimary
Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Richard S. Hudes' practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hudes practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Chesapeake Urology Associates | Available with a free account |
| +1 more site and 2 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Hudes practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Richard S. Hudes is one of 100 radiation oncologists in Maryland
Radiation oncology is Dr. Hudes' primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Hudes is licensed in Maryland.
Specialties and state licenses
- Radiation oncology, MarylandPrimary
Radiation oncologists near Dr. Hudes
Counts of radiation oncologists with a Dmand AI profile, by place and practice. Each opens the list.
100radiation oncologists in Maryland
2radiation oncologists in Owings Mills
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Richard S. Hudes billed Medicare for 6,500 services in 2024
CMS data shows 6,500 Medicare services from Dr. Hudes across 26 procedure codes in 2024, for 452 Medicare patients. Medicare paid $713,685 for them.
Medicare services, 20246,500
Medicare patients452
Paid by Medicare$713,685
Procedure codes26
Dr. Hudes' Medicare services by type, 2023 to 2024
- 2023
- 2024
- Other services
- 2023: 3,3912024: 3,6377%
- Imaging
- 2023: 2,8862024: 2,42816%
- Office and hospital visits
- 2023: 5182024: 43516%
Where Dr. Hudes' Medicare services took place, 2024
- In an office4,75773%
- In a facility1,74327%
Dr. Hudes compared with the Maryland median for radiation oncologists, 2024
- Dr. Hudes
- Maryland median
- Medicare services
- 6,500vs 2,0763.1 times
- Medicare patients
- 452vs 24088% above
- Part D claims
- 58vs 252.3 times
Medians across 93 radiation oncologists in Maryland with Dmand AI profiles that report each measure.
Dr. Hudes' most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Hudes?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Hudes and other radiation oncologists in Maryland.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Richard S. Hudes treated 452 Medicare patients in 2024, average age 74
CMS counts 452 Medicare patients who saw Dr. Hudes in 2024. The largest group is 65 to 74, with 224 patients. 75% of them have cancer, and 75% have high blood pressure. 8% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Hudes' median patient age at 70, with 14% women.
Medicare patients, 2024452
Average age74
Average risk score1.11
Also on Medicaid8%
Dr. Hudes' Medicare patients by age, 2024
Dr. Hudes' Medicare patients by sex, 2024
- Women9721%
- Men35579%
Chronic conditions among Dr. Hudes' Medicare patients, 2024
- Cancer75%
- High blood pressure75%
- High cholesterol75%
- Arthritis42%
- Diabetes34%
- Ischemic heart disease26%
- Chronic kidney disease20%
- Anxiety16%
Share of Medicare patients with each condition. A patient can have several.
Dr. Hudes' patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women14%
- Men86%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Richard S. Hudes wrote 88 Medicare Part D claims in 2024
In 2024, Dr. Hudes wrote 88 Medicare Part D claims for 38 patients. 95% of them were for generic drugs. CMS names the drug for 58 of them, across 1 drug with 11 or more claims each, at $1,151 in total drug cost. In 2023, CMS named 48 claims across 1 drug.
Part D claims, 202488
Drugs named by CMS1
Total drug cost$1,151
Part D patients38
Dr. Hudes' Part D claims by kind of drug, 2024
- Generic84 claims95%
- Brand-name and other4 claims5%
Dr. Hudes' most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 482024: 5821%
Drugs named by CMS: 1 in 2024, 1 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Richard S. Hudes scored 100 out of 100 in Medicare's MIPS program for 2024
CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Hudes for performance year 2024, reported as part of a group. Dr. Hudes accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Hudes as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Dr. Hudes' MIPS scores, performance year 2024
- 100of 100Final score
- 100of 100Promoting Interoperability
- 40of 100Improvement Activities
Each score is out of 100. The final score weighs the categories CMS scored for this clinician.
Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026
For MedTech and pharma teams
Find radiation oncologists like Dr. Hudes by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Richard S. Hudes has 8 publications on record
Dmand AI links 8 papers to Dr. Hudes, published from 2015 to 2024. 2015 was the busiest year, with 2. The most frequent topics are Prostatic Neoplasms, Radiotherapy, Intensity-Modulated and Rectum. Dr. Hudes has published most often in Pract Radiat Oncol. Dr. Hudes' most frequent co-authors are David C. Beyer, MD, Jeffrey A. Bogart, MD and Michael F. Kos, MD.
Papers8
Years published2015 to 2024
Dr. Hudes' papers by year, 2015 to 2024
Topics Dr. Hudes writes about most
- Prostatic Neoplasms
- Radiotherapy, Intensity-Modulated
- Rectum
Dr. Hudes' most frequent co-authors
- David C. Beyer, MD5 shared papers
- Jeffrey A. Bogart, MD5 shared papers
- Michael F. Kos, MD5 shared papers
Recent publications by Dr. Hudes
Int J Radiat Oncol Biol Phys
Absorbable ImplantsFiducial MarkersProstatic Neoplasms
Pract Radiat Oncol
ProstateProstatic NeoplasmsRectum
Prostatic NeoplasmsRadiotherapy, Intensity-ModulatedSexual Behavior
See who Dr. Hudes researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Hudes works with, so you can find a warm path to the right radiation oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Richard S. Hudes has worked on 9 clinical trials
Dmand AI links Dr. Hudes to 9 clinical trials, 7 of them phase 3 studies. 7 are still active or recruiting. Conditions studied include Lung Neoplasms, Prostatic Neoplasms and Prostatic Diseases. Alliance for Clinical Trials in Oncology sponsors the most, 4.
Clinical trials with Dr. Hudes by phase
- NonePhase 1: no trials
- 2Phase 2: 2 trials
- 7Phase 3: 7 trials
- NonePhase 4: no trials
Conditions in Dr. Hudes' trials
- Lung Neoplasms
- Prostatic Neoplasms
- Prostatic Diseases
- Thoracic Neoplasms
- Breast Neoplasms
Investigators on the most trials with Dr. Hudes
- Thomas J. Gergel, MD5 shared trials
- Andrew Stuart Camarata, MD4 shared trials
- Brian K. Chang, MD4 shared trials
Recent clinical trials with Dr. Hudes
Preoperative Extended Chemotherapy vs. Chemotherapy Plus Hypofractionated Radiation Therapy for Borderline Resectable Adenocarcinoma of the Head of the Pancreas (opens in a new tab)
Status unknownPhase 2
Radiation therapyFOLFOXmFOLFIRINOX
Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC) (opens in a new tab)
Active, not recruitingPhase 3
Lung NeoplasmsThoracic NeoplasmsAtezolizumabCarboplatinCisplatin
Radiation Therapy With or Without Apalutamide in Treating Patients With Recurrent Prostate Cancer, the BALANCE Trial (opens in a new tab)
Active, not recruitingPhase 2
Prostatic NeoplasmsProstatic DiseasesApalutamideExternal Beam Radiation Therapy
Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients with Stage IIa-IIIa Breast Cancer (opens in a new tab)
Active, not recruitingPhase 3
Carcinoma, LobularCarcinoma, Ductal, BreastHypofractionated Radiation TherapyRadiation Therapy
Stereotactic Body Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Stage IIA-B Prostate Cancer (opens in a new tab)
Active, not recruitingPhase 3
Intensity-Modulated Radiation TherapyStereotactic Body Radiation Therapy
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Richard S. Hudes received $4,132 in industry payments from 2016 to 2025
CMS Open Payments shows 90 general payments to Dr. Hudes from 29 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Boston Scientific Corporation paid the most, $608.
General payments to Dr. Hudes by program year, 2016 to 2025
General payments to Dr. Hudes by kind, 2016 to 2025
$4.1Kin total
- Food and beverage$4,02097%
- Speaker and faculty fees$1123%
Companies that paid Dr. Hudes the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Richard S. Hudes graduated from Medical College of Georgia School of Medicine
Dr. Hudes graduated from Medical College of Georgia School of Medicine in 1995.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Richard S. Hudes's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data |
| Primary practice, affiliations and health system | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Richard S. Hudes
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Richard S. Hudes' NPI number?
Dr. Richard S. Hudes' NPI number is 1891796926. It was assigned on August 10, 2005, and it is active in the NPI Registry.
What kind of doctor is Dr. Richard S. Hudes?
Dr. Richard S. Hudes is a radiation oncologist in Owings Mills, Maryland. The primary specialty in the NPI Registry is Radiation Oncology Physician (taxonomy code 2085R0001X).
Where does Dr. Richard S. Hudes practice?
Dr. Hudes practices at 2 Park Center Ct, Owings Mills, MD 21117. Dr. Hudes' primary practice is Chesapeake Urology Associates in Owings Mills, Maryland. Dmand AI also links Dr. Hudes to 2 medical groups.
What is Dr. Richard S. Hudes' office phone number?
The practice phone on file for Dr. Hudes is (410) 581-1600.
What is Dr. Richard S. Hudes' medical license number?
Dr. Hudes holds Maryland license D0055908.
Which hospitals is Dr. Richard S. Hudes affiliated with?
Dr. Hudes is affiliated with Ascension Saint Agnes Hospital.
What medical group is Dr. Richard S. Hudes part of?
Dr. Hudes is linked to Chesapeake Urology Associates. Dmand AI links Dr. Hudes to 2 more medical groups.
Does Dr. Richard S. Hudes accept Medicare?
Yes. CMS data shows Dr. Hudes billed Medicare for 6,500 services in 2024, and Dr. Hudes accepts Medicare assignment.
Does Dr. Richard S. Hudes offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Hudes as offering telehealth services.
What is Dr. Richard S. Hudes' MIPS score?
Dr. Hudes' MIPS final score for performance year 2024 is 100 out of 100, reported as part of a group.
Show 8 more questionsShow fewer questions
How many Medicare patients does Dr. Richard S. Hudes see?
CMS counts 452 Medicare patients who saw Dr. Hudes in 2024, with an average age of 74.
What services does Dr. Richard S. Hudes bill to Medicare?
In 2024, Dr. Hudes' most billed Medicare services were medicare temporary code (Q3001), medicare service (G6015) and medicare service (G6002).
Where did Dr. Richard S. Hudes go to medical school?
Dr. Hudes graduated from Medical College of Georgia School of Medicine in 1995.
What drugs does Dr. Richard S. Hudes prescribe most?
In 2024 Medicare Part D data, Dr. Hudes' most prescribed drugs by claims were Tamsulosin HCl.
Has Dr. Richard S. Hudes received payments from drug or device companies?
CMS Open Payments shows $4,132 in general payments to Dr. Hudes from 29 companies from 2016 to 2025. The largest total came from Boston Scientific Corporation.
How long has Dr. Richard S. Hudes been practicing?
Dr. Hudes graduated from medical school in 1995, 31 years ago.
Does Dr. Richard S. Hudes do research?
Dmand AI links 8 publications to Dr. Hudes, published from 2015 to 2024. Dr. Hudes has worked on 9 clinical trials.
Who does Dr. Richard S. Hudes publish with?
Dr. Hudes' most frequent co-authors are David C. Beyer, MD (5 shared papers), Jeffrey A. Bogart, MD (5 shared papers) and Michael F. Kos, MD (5 shared papers).
Selling to radiation oncology practices?
See radiation oncologists in Maryland by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card